Hirschberg H, Bergh O J, Thorsby E
J Exp Med. 1980 Aug 1;152(2 Pt 2):249s-255s.
Human endothelial cells were obtained by collagenase digestion of the umbilical vein wall, explanted into tissue culture, and grown as monolayers of cells. Endothelial cells extracted from these monolayers were specifically lysed by anti-HLA-DR alloantisera. Moreover, the stimulating capacity of these endothelial cells toward allogeneic peripheral blood mononuclear lymphocytes was specifically and significantly inhibited by the presence of relevant anti-HLA-DR antisera. Endothelial cells that expressed HLA-DR determinants were also capable of substituting for macrophages in the lymphoproliferative response of purified T cells to soluble protein antigens. Moreover, in concordance with the results previously reported in which macrophages were employed, the endothelial cell donor should share HLA-DR determinants with the T cell donor for an optimal response to occur.
通过用胶原酶消化脐静脉壁获得人内皮细胞,将其接种到组织培养物中,并作为单层细胞生长。从这些单层细胞中提取的内皮细胞被抗HLA - DR同种异体抗血清特异性裂解。此外,相关抗HLA - DR抗血清的存在特异性且显著地抑制了这些内皮细胞对同种异体外周血单个核细胞的刺激能力。表达HLA - DR决定簇的内皮细胞在纯化的T细胞对可溶性蛋白抗原的淋巴细胞增殖反应中也能够替代巨噬细胞。此外,与先前报道的使用巨噬细胞的结果一致,内皮细胞供体应与T细胞供体共享HLA - DR决定簇,以产生最佳反应。